Roughly 15 current, individually attributable price targets were reviewed. They span from a low of $305 (JLPascual, which downgraded the stock to Sell) to a high of $425 (Barclays, Overweight). The arithmetic mean of all these targets is about $369 — only about 9% above the latest price. Because that overall mean sits below the 10% threshold that would make it a meaningful forward objective, the central target here is instead calculated as the average of the targets above the current price, which works out to roughly $379 and is rounded to $380.
Views are split rather than uniform. The most bullish names — Barclays at $425, BofA Securities at $400, UBS at $395, and Wells Fargo at $390 — emphasize scale, earnings durability, and a premium multiple. A broad middle cluster, including Morgan Stanley, HSBC, RBC Capital, TD Cowen, and Evercore ISI, sits between roughly $361 and $377. The cautious end, including Citigroup at $350 and Baird at $312, focuses on valuation and near-term capital-markets softness. These differences are not random; they reflect genuine disagreement about how much of a premium the franchise deserves. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The latest verified price is about $337, giving JPM a market value near $895 billion and a trailing P/E (price-to-earnings ratio) of about 14x. Reaching $380 would require an upside of roughly 13%, a substantial move for a mega-cap bank that has already more than tripled over the past three years. The shares trade on about 13x forward earnings, a premium to the roughly 11x multiple of the broader U.S. banking group — a premium bulls argue is earned, and skeptics argue leaves less margin for error.
The fundamental case rests on durability. Third-quarter revenue grew year over year across Consumer & Community Banking, the Commercial & Investment Bank, and Asset & Wealth Management. Management's preliminary 2027 net interest income (NII) outlook came in above consensus, implying roughly $117 billion — up about 10% — driven by balance-sheet expansion rather than a simple bet on interest rates. BofA Securities' Ebrahim Poonawala, who rates the stock a Buy with a $400 target, also points to roughly $1.5 trillion of cash and securities plus excess capital as a defensive buffer. A return on equity near 18% and a dividend yield near 2% round out the support case. From what I see, the diversified revenue streams provide a solid foundation here.
The obstacles are equally concrete. JPM posted a rare profit miss in the third quarter, with EPS (earnings per share) of about $5.75 versus a roughly $5.94 consensus, as dealmaking and bond trading lost momentum. Credit quality is an open question: CEO Jamie Dimon has publicly cautioned on credit conditions, and reserves and provisioning remain areas to watch. Finally, the valuation premium means multiple compression — rather than any fundamental breakdown — could keep the stock below $380 even if earnings meet expectations.
The chart frames the challenge. The 52-week range runs from $279.10 to $366.50, and the $366.50 level now acts as major resistance — the stock must break decisively above its prior high for $380 to become reachable. Below the current price, the $330 area and the psychological $350 mark are near-term reference points. Because $380 sits above the established range, it represents a technical breakout target as much as a valuation one. I’m watching this closely as the resistance level could define near-term momentum.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms differ in their assumptions about rates and credit. The next quarterly report is scheduled for January 2027. Investors should watch NII and margin trends, credit-loss provisions, trading and investment-banking revenue, management's updated expense and capital commentary, and any FOMC (Federal Open Market Committee) rate decisions that could reshape deposit costs and lending yields. Upgrades, downgrades, and target revisions from the firms above will also signal how the $380 objective is holding up.
Can JPM reach $380? The target — the average of analyst price targets above the current price — implies a substantial gain of about 13% and would take the stock above its prior record high. The supporting case is strong: diversified revenue growth, above-consensus 2027 NII guidance, and a balance sheet with exceptional loss-absorbing capacity. The counter-case is just as real: a rare earnings miss, a valuation premium versus peers, and lingering credit uncertainty. With targets spanning $305 to $425, the Street itself is divided. Reaching $380 is not a matter of certainty but of whether the bank's earnings durability and premium valuation both hold into 2027 — a question that the January earnings report, credit trends, and rate decisions will help answer.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single metric, the system scans for shifting trends so traders can discover opportunities, monitor existing positions, and spot reversals more efficiently. For investors tracking a large-cap name like JPM, such tools can complement traditional research by flagging momentum changes earlier than manual review might. I find these signals helpful when cross-checking my own views on names like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where JPM declined for three days, in 148 of 257 cases, the price declined further within the following month. The odds of a continued downward trend are 58%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JPM as a result. In 38 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.
The Moving Average Convergence Divergence Histogram (MACD) for JPM turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 24 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.
JPM moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for JPM crossed bearishly below the 50-day moving average on November 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 43%.
The RSI Indicator entered the oversold zone -- be on the watch for JPM's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where JPM advanced for three days, in 217 of 364 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
JPM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 189 of 342 cases where JPM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 26, placing this stock better than average.
The Tickeron Seasonality Score of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating fairly steady price growth. JPM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: JPM's P/B Ratio (2.515) is slightly higher than the industry average of (1.500). P/E Ratio (14.307) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (1.562) is also within normal values, averaging (2.139). Dividend Yield (0.020) settles around the average of (0.035) among similar stocks. P/S Ratio (4.888) is also within normal values, averaging (3.867).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks